The development and application of in silico models for drug induced liver injury-Reference-Cited by-同舟云学术

The development and application of in silico models for drug induced liver injury

Published:2018 Issue:15 Volume:8 Page:8101-8111
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Li Xiao¹²³⁴⁵^ORCID,Chen Yaojie¹²³,Song Xinrui¹²³,Zhang Yuan¹²³,Li Huanhuan¹²³,Zhao Yong¹²³⁴⁵

Affiliation:

1. Beijing Beike Deyuan Bio-Pharm Technology Co. Ltd.

2. Beijing 100094

3. China

4. Beijing Key Laboratory of Cloud Computing Key Technology and Application

5. Beijing Computing Center

Abstract

Drug-induced liver injury (DILI), caused by drugs, herbal agents or nutritional supplements, is a major issue for patients and the pharmaceutical industry.

Funder

Beijing Postdoctoral Research Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2018/RA/C7RA12957B

Reference59 articles.

1. Predicting drug-induced liver injury: The importance of data curation

2. FDA-approved drug labeling for the study of drug-induced liver injury

3. Hepatitis induced by traditional Chinese herbs; possible toxic components.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches;Chemical Biology & Drug Design;2024-08

2. Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches;2024-04-18

3. Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet;Pharmacological Research;2024-02

4. InterDILI: interpretable prediction of drug-induced liver injury through permutation feature importance and attention mechanism;Journal of Cheminformatics;2024-01-03

5. Computational precision therapeutics and drug repositioning;Comprehensive Precision Medicine;2024